🇺🇸 FDA
Pipeline program

Crofelemer Placebo Powder for Oral Solution

NP303-104

Phase 2 small_molecule active

Quick answer

Crofelemer Placebo Powder for Oral Solution for Microvillous Inclusion Disease (MVID) is a Phase 2 program (small_molecule) at Pharma Mar S.A. with 1 ClinicalTrials.gov record(s).

Program details

Company
Pharma Mar S.A.
Indication
Microvillous Inclusion Disease (MVID)
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials